Total Equity - Yifan Pharmaceutical Co Ltd (SZSE:002019) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 13.15 CNY -1.57%

Updated:

Yifan Pharmaceutical Co Ltd
Total Equity

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

|

Adjust for Inflation

Yifan Pharmaceutical Co Ltd
Total Equity Peer Comparison

C

1093

H

3692

600436

600276

000538

Company		Total Equity	CAGR 3Y	CAGR 5Y	CAGR 10Y
Y	Yifan Pharmaceutical Co Ltd SZSE:002019	Total Equity ¥8.3B	CAGR 3-Years -1%	CAGR 5-Years 4%	CAGR 10-Years 31%
C	CSPC Pharmaceutical Group Ltd HKEX:1093	Total Equity ¥33.2B	CAGR 3-Years 14%	CAGR 5-Years 17%	CAGR 10-Years 19%
H	Hansoh Pharmaceutical Group Company Ltd HKEX:3692	Total Equity ¥25.8B	CAGR 3-Years 13%	CAGR 5-Years 60%	CAGR 10-Years N/A
	Zhangzhou Pientzehuang Pharmaceutical Co Ltd SSE:600436	Total Equity ¥13.4B	CAGR 3-Years 17%	CAGR 5-Years 19%	CAGR 10-Years 18%
	Jiangsu Hengrui Pharmaceuticals Co Ltd SSE:600276	Total Equity ¥40.5B	CAGR 3-Years 8%	CAGR 5-Years 15%	CAGR 10-Years 20%
	Yunnan Baiyao Group Co Ltd SZSE:000538	Total Equity ¥39.9B	CAGR 3-Years 1%	CAGR 5-Years 14%	CAGR 10-Years 15%

See Also

Based on the financial report for Mar 31, 2024, Yifan Pharmaceutical Co Ltd's Total Equity amounts to 8.3B CNY.

Over the last year, the Total Equity growth was -7%. The average annual Total Equity growth rates for Yifan Pharmaceutical Co Ltd have been -1% over the past three years , 4% over the past five years , and 31% over the past ten years .

Join more than 143,300+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.